兽医肿瘤学市场:各动物类型，各治疗类型，剂型，各用途，各流通管道，各地区- 规模，占有率，展望，机会分析，2022年～2030年

市场动态

市场参与者扩大采用无机增长战略，如研发计划和伙伴关係，如兽医癌症治疗宣传活动，预计将在预测期内推动市场增长。

本调查的主要特征

• 本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球兽医肿瘤学市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
• 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
• 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
• 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球兽医肿瘤学市场的主要参与者之企业简介。
• 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 全球兽医肿瘤学市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以透过全球兽医肿瘤学市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

• 调查目的
• 前提条件
• 简称的说明

第2章 市场展望

• 报告内容
  • 市场定义和范围
• 摘要整理
  • 市场概述:各动物类型
  • 市场概述:各治疗类型
  • 市场概述:给药模式别
  • 市场概述:各应用领域
  • 市场概述:各流通管道
  • 市场概述:各地区
• 连贯机遇地图(COM)

第3章 市场动态，法规，趋势分析

• 市场动态
  • 促进因素
  • 阻碍因素
  • 市场机会
• 影响分析
• 兽医学的肿瘤的预防和控制的配合措施
• 放射线治疗
• 市场趋势
• 产品回收
• 流行病学
• 主要的发展情形
• 猫的癌症
• 狗的癌症
• 动物用医药品常使用的化疗剂
• 法规方案
• 动物用医药品专利资讯
• 动物用癌症启发活动
• M&A(合併·收购
• PEST分析

第4章 兽医肿瘤学的全球市场-冠状病毒(COVID-19)疫情的影响

• 整体影响
• 政府的配合措施
• COVID-19市场的影响

第5章 兽医肿瘤学的全球市场，各动物类型，2017年～2030年

• 宠物
• 市场规模·预测·YoY成长率，2017年～2030年
• 市场规模，预测，与前一年同期比较成长率，2017年～2030年
• 市场规模，预测，与前一年同期比较成长率，2017-2030年
• 畜产动物

第6章 兽医肿瘤学的全球市场(各治疗类型):2017年～2030年

• 化疗
• 联合治疗
• 免疫疗法
• 标靶治疗

第7章 兽医肿瘤学的全球市场，剂型，2017年～2030年

• 口服给药
• 静脉注射

第8章 兽医肿瘤学的全球市场:各用途，2017年～2030年

• 狗淋巴瘤
• 骨癌(OSA)
• 肥胖细胞肿(Mast Cell Cancer
• 黑色素瘤
• 多发性骨髓瘤

第9章 兽医肿瘤学的全球市场(各流通管道):2017年～2030年

• 医院药局
• 政府机关
• 零售药局

第10章 兽医肿瘤学的全球市场:各地区，2017年～2030年

• 北美
• 美国
• 加拿大
• 南美
• 巴西
• 墨西哥
• 阿根廷
• 其他的南美地区
• 欧洲
• 英国
• 德国
• 义大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲
• 亚太地区
• 中国
• 印度
• 日本
• ASEAN
• 澳洲
• 韩国
• 其他亚太地区
• 中东地区
• GCC
• 以色列
• 其他的中东地区
• 非洲
• 北非
• 中非
• 南非

第11章 竞争情形

• 企业简介
  • Zoetis Inc.
  • Elanco
  • AB Science
  • Boehringer Ingelheim International GmbH
  • Zenoaq
  • VetDC
  • Morphogenesis, Inc.
  • Karyopharm Therapeutics, Inc.
  • Regeneus Ltd.
  • AdvaVet, Inc.
  • Rhizen Pharmaceutical SA

第12章 章节

• 参考文献
• 调查手法的介绍
• 关于出版社

Veterinary oncology is subspecialty of veterinary medicine that deals with the diagnosis and treatment of cancer in animals. With emerging technologies, the use of biotechnology products in veterinary medicines is increasing. Despite the costs that many times accompany the development of novel biotechnological products, recombinant virus vector vaccines, recombinant proteins such as bioactive cytokines and immunotherapeutic allergens, therapeutic antibodies, and oncolytic viruses are the result of advancements in biotechnology for veterinary medicines. The benefits associated with using biotechnology products are large-scale production, reduced costs, long-term action, and multiple antigen vaccines. A veterinary oncologist has specialized knowledge in the diagnosis of cancer, the staging of tumors, the development of treatment plans, and the administration of chemotherapy. Veterinary oncologists determine the most appropriate course of treatment and coordinate the treatment program for pets with cancer. They also frequently serve as consultants to veterinarians in private practice to ensure that their patients receive the best treatment possible for their cancer. There is ongoing research and clinical trials to develop new and effective treatment options for pets with cancer. Many veterinary medical advances have been made in recent years. One breakthrough treatment was the development of the ONCEPT Canine Melanoma Vaccine. ONCEPT Canine Melanoma Vaccine therapeutic vaccine is manufactured by Merial, a world leading, innovation-driven animal health company and the maker of many canine vaccines, including the world's leading rabies vaccines.

Market Dynamics

Increasing adoption of inorganic growth strategies such as partnership by the key players in the market for research and development program and awareness programs for the veterinary oncology treatment is expected to drive the market over the forecast period. For instance, in August 2022, a Siemens Healthineers company, a healthcare company, and the University of Illinois Veterinary Teaching Hospital partnered to provide a 2-day clinical educational program in veterinary radiation oncology. According to a company release, the inaugural clinical 'school,' hosted by Varian Veterinary Oncology, occurred on from August 12 - 13, 2022. Custom designed for the veterinary radiation oncology team, the curriculum will hone in on clinical workflows, clinical implementation, treatment planning, and treatment delivery. Participants will obtain instruction on radiotherapy and similar topics and will participate in hands-on workshops.

Key features of the study:

• This report provides an in-depth analysis of the global veterinary oncology market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global veterinary oncology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., and Rhizen Pharmaceutical SA.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global veterinary oncology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary oncology market

Detailed Segmentation:

• Global Veterinary Oncology Market, By Animal Type:
  • Companion Animal
    • Equine
    • Canine
    • Feline
  • Livestock Animal
• Global Veterinary Oncology Market, By Therapy Type:
  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy
• Global Veterinary Oncology Market, By Mode of Administration:
  • Oral
  • Intravenous
• Global Veterinary Oncology Market, By Application:
  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
• Global Veterinary Oncology Market, By Distribution Channel:
  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
• Global Veterinary Oncology Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Zoetis Inc.*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Elanco
  • AB Science
  • Boehringer Ingelheim International GmbH
  • Zenoaq
  • VetDC
  • Morphogenesis, Inc.
  • Karyopharm Therapeutics, Inc.
  • Regeneus Ltd.
  • AdvaVet, Inc.
  • Rhizen Pharmaceutical SA

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Animal Type
  • Market Snapshot, By Therapy Type
  • Market Snapshot, By Mode of Administration
  • Market Snapshot, By Application
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Initiatives for Prevention and Control of Veterinary Oncology
• Radiation Therapy
• Market Trends
• Product Recall
• Epidemiology
• Key Developments
• Cancers in Cats
• Cancers in Dogs
• Chemotherapy Agents Commonly used in Veterinary Medicine
• Regulatory Scenario
• Veterinary Medicines: Patent Information
• Veterinary Cancer: Awareness Campaign
• Mergers and Acquisitions
• PEST Analysis

4. Global Veterinary Oncology Market- Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the market

5. Global Veterinary Oncology Market, By Animal Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Companion Animal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Equine
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Canine
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Feline
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Livestock Animal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Veterinary Oncology Market, By Therapy Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Chemotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Combination Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Immunotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Targeted Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Veterinary Oncology Market, By Mode of Administration, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Intravenous
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Veterinary Oncology Market, By Application, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Canine Lymphoma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Osteosarcoma (OSA)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Mast Cell Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Melanoma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Multiple Myeloma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Veterinary Oncology Market, By Distribution Channel, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Government Agencies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

10. Global Veterinary Oncology Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

11. Competitive Landscape

• Company Profiles
  • Zoetis Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Elanco
  • AB Science
  • Boehringer Ingelheim International GmbH
  • Zenoaq
  • VetDC
  • Morphogenesis, Inc.
  • Karyopharm Therapeutics, Inc.
  • Regeneus Ltd.
  • AdvaVet, Inc.
  • Rhizen Pharmaceutical SA
• Analyst Views

12. Section

• References
• Research Methodology
• About Us